Maximus Inc. (MMS) Rises 4.48% After Earnings, Misses both EPS and Revenue

2025-11-20 · Stocks · QuoteReporter

Post Earning Analysis

Maximus Inc. (MMS) Rises 4.48% After Earnings, Misses EPS and Misses Revenue

MAXIMUS, Inc., founded in 1975 and based in McLean, VA, specializes in managing government health and human services programs and providing related technology solutions. The company operates through three main segments: U.S. Services, U.S. Federal Services, and Outside the U.S. These segments encompass a range of services including business process services, appeals, assessments, IT modernization, and system development for both domestic and international governments and commercial clients.

Maximus, identified by its ticker MMS, recently disclosed its fiscal Q4 earnings which have notably fallen short of Wall Street expectations. The company’s earnings and revenue for the fourth quarter did not meet the estimates set by analysts, as reported on November 20, 2025. This underperformance also extends to their sales figures for the third quarter of the calendar year 2025, which similarly failed to meet expectations. These results could potentially impact the stock negatively as investors often react to earnings misses by adjusting their holdings. The details of these financial outcomes were covered across multiple financial news platforms, indicating significant interest in the company’s performance. This series of reports comes right after anticipatory analyses that were trying to predict the company’s financials just days before the earnings were released. The overall sentiment from these reports suggests a cautious or bearish outlook for Maximus’s stock in the near term.

The current price of the asset is $80.36, showing a significant daily increase of 4.48%. Despite today’s positive movement, the price trends over various periods present a mixed picture. The asset is currently trading below its 20-day and 50-day moving averages by 2.45% and 6.16% respectively, indicating a short to medium-term bearish trend. However, it is trading above the 200-day moving average by 6.58%, suggesting a longer-term bullish outlook.

The recent price is 12.8% below the 52-week and YTD highs of $92.16 but has risen 27.45% from the 52-week and YTD lows of $63.05, showing significant recovery over the longer period. The week’s trading range has been narrower, with the price now closer to the week’s low of $77.59 than to the high of $84.26.

The RSI at 40.5 indicates that the asset is neither overbought nor oversold, while a MACD of -1.89 suggests that the asset is currently experiencing downward momentum. This combination of indicators and price performance across different timeframes suggests a cautious market sentiment with potential for both risk and opportunity in the near term.

Maximus (NYSE: MMS) reported its financial outcomes for the fourth quarter and the entire fiscal year of 2025, ending September 30. The company saw a year-over-year revenue increase of 2.4%, reaching $5.43 billion, attributed to a 3.9% organic growth primarily in the U.S. Federal Services Segment. The operating margin improved to 9.7% from 9.2%, and the adjusted EBITDA margin rose to 12.9% from the previous year’s 11.6%.

Diluted earnings per share (EPS) for the year climbed to $5.51 from $4.99, with adjusted EPS at $7.36, up from $6.11. Operating cash flow stood at $429 million, with free cash flow of $366 million. Notably, Q4 alone generated $642 million in free cash flow. The company also returned value to shareholders through the repurchase of 5.8 million shares for $457 million and declared a quarterly dividend of $0.30 per share.

Looking ahead, Maximus set its fiscal 2026 guidance with expected revenue between $5.225 billion and $5.425 billion, an adjusted EBITDA margin of about 13.7%, and adjusted EPS ranging from $7.95 to $8.25. Projected free cash flow is anticipated to be between $450 million and $500 million. This guidance reflects the company’s ongoing operational efficiencies and market position strength.

Earnings Trend Table

The EPS (Earnings Per Share) trends over the observed quarters show significant variability in both the reported EPS figures and the surprise percentages relative to the estimates. Notably, there is a mix of both underperformances and overperformances compared to the analyst estimates.

Starting from November 2023, the company underperformed against expectations with a -6.80% surprise. This trend of underperformance continued into February 2024, although the surprise was marginal at -2.97%. However, a notable improvement was observed by May 2024, where the reported EPS exceeded estimates by 28.01%, followed by a modest overperformance in August 2024 with an 8.96% positive surprise.

The variability became more pronounced towards the end of 2024 and throughout 2025. November 2024 saw a significant shortfall in EPS, underperforming estimates by -20.40%. This was followed by a substantial underperformance in February 2025, with a -34.91% surprise, marking the lowest performance relative to expectations. However, there was a dramatic turnaround in May 2025, where the company significantly outperformed expectations with a 45.65% positive surprise. Yet, by November 2025, the trend reverted to a notable underperformance at -19.02%.

Overall, the EPS trends indicate a pattern of significant fluctuations between quarters, with alternating periods of positive and negative surprises, suggesting potential volatility in operational performance or challenges in forecasting earnings accurately.

Dividend Payments Table

The dividend data spanning from February 2024 to November 2025 indicates a consistent dividend payout of $0.3 per share each quarter. This uniformity in dividend distribution suggests a stable financial strategy by the entity in question, maintaining shareholder returns without variation across the observed periods. The regularity of these payments, disbursed quarterly in the middle of the month (either on the 14th or 15th), reflects a predictable and reliable income stream for investors, which is often indicative of a company’s robust operational health and a commitment to returning value to shareholders. Such consistency in dividend payouts can be appealing to both current and potential investors looking for steady income in their investment portfolios. This trend could potentially signal a conservative financial posture, prioritizing sustainability over more aggressive growth policies that might otherwise divert funds from dividends to expansion or other investments.

In the most recent sequence of rating changes by different firms, there has been notable activity affecting investment perspectives:

1. Raymond James – January 2, 2025: This firm upgraded its rating from “Market Perform” to “Outperform” with a target price set at $90. This upgrade suggests a positive shift in Raymond James’ outlook on the stock’s performance potential, indicating expectations for the stock to outperform the general market or its sector peers.

2. Raymond James – January 3, 2024: Approximately one year prior to the upgrade, Raymond James had downgraded the same stock from “Outperform” to “Market Perform.” This earlier adjustment did not include a specific target price, reflecting a neutral stance, where the firm did not foresee the stock significantly outperforming or underperforming the market.

3. Stifel – August 18, 2023: Stifel initiated coverage on the stock with a “Buy” rating and a target price of $102. This initiation at a relatively high target price indicates Stifel’s strong confidence in the stock’s potential to generate significant returns.

4. Raymond James – June 28, 2021: Over four years prior to their 2025 upgrade, Raymond James downgraded the stock from “Strong Buy” to “Outperform” and adjusted the target price from $110 to $105. This action represented a slight tempering of enthusiasm but still maintained a positive outlook, suggesting a moderation of bullish expectations but not a complete reversal.

These movements reflect a dynamic and evolving perspective on the stock by Raymond James, marked by initial optimism, a period of neutrality, and a return to a positive outlook. Stifel’s initiation with a “Buy” rating adds an external viewpoint that aligns more closely with Raymond James’ earlier and later assessments, indicating a generally favorable view of the stock’s prospects over the long term.

The current price of the stock stands at $80.36. Analyzing the ratings summary, there is a notable variation in the target prices set by different analysts over time. The most recent evaluation from Raymond James on January 2, 2025, upgraded the stock from Market Perform to Outperform, setting a target price at $90. This suggests a potential upside of approximately 12% from the current price. Earlier, Stifel had initiated coverage with a Buy rating and a target price of $102 on August 18, 2023, indicating a potential increase of about 27%. However, Raymond James had previously downgraded the stock multiple times, the last of which set the target at $105 after a downgrade from Strong Buy to Outperform on June 28, 2021.

This trend in the target prices, alongside the latest upgrade, might indicate growing optimism about the stock’s future performance despite previous reservations. The information on earnings per share (EPS) and dividends is not provided, which limits a comprehensive financial analysis. However, the target price adjustments and ratings provide insights into market expectations and sentiment shifts among analysts over the observed period.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.